与致命类阿片混合的两种未经批准的药物正在助长苏德伯里(Sudbury)激增的过量危机,引发紧急公共卫生警告。 Two unapproved drugs, mixed with deadly opioids, are fueling Sudbury’s soaring overdose crisis, prompting urgent public health warnings.

根据社区药物战略和多伦多药物检查服务,两种危险、未经批准的药物 -- -- 氯乙烯(一种强效类阿片)和苯并二甲二氮杂卓(一种苯并二氮杂卓) -- -- 正在苏德伯里药物供应中流通,剂量过大的风险日益增加。 Two dangerous, unapproved drugs—cychlorphine, a potent opioid, and Deschlorodemethyldiazepam, a benzodiazepine—are circulating in Sudbury’s drug supply, increasing overdose risks, according to the Community Drug Strategy and Toronto’s Drug Checking Service. 这两种物质都可能与芬太尼、卡芬塔尼(carfentanil)或苯丙胺(xylazine)混合,甚至导致少量的致死。 Both substances may be mixed with fentanyl, carfentanil, or xylazine, making even small amounts lethal. 截至2025年8月,Sudbury和Manitoulin地区与类阿片有关的死亡率达到每100 000人53.7人,超过安大略省平均数的三倍。 As of August 2025, the Sudbury and Manitoulin region’s opioid-related death rate reached 53.7 per 100,000—more than triple Ontario’s average. 官员敦促携带naloxone, 避免药物混合, 使用低剂量, 绝不单独使用。 Officials urge carrying naloxone, avoiding substance mixing, using lower doses, and never using alone. 吸毒过量症状包括呼吸迟缓、皮肤蓝刺和反应不灵敏。 Overdose symptoms include slowed breathing, blue-tinged skin, and unresponsiveness. 在国家过量反应服务处和布拉夫App的支持下,可在多个地点在线提供freenaloxone药包。 Free naloxone kits are available at multiple locations and online, with support through the National Overdose Response Service and the Brave App.